Artiva Biotherapeutics, Inc. (ARTV)

NASDAQ: ARTV · Real-Time Price · USD

11.29

+0.49 (4.54%)

At close: May 4, 2026, 4:00 PM EDT

11.46

+0.17 (1.52%)

After-hours: May 4, 2026, 7:38 PM EDT

Artiva Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	279	106	245	-	-	-
Market Cap Growth	397.99%	-56.91%	-	-	-	-
Enterprise Value	181.99	-2.49	59.43	0	0	0
Last Close Price	11.29	4.29	10.08	-	-	-
PE Ratio	-	-1.25	-1.73	-	-	-
PS Ratio	-	-	975.54	-	-	-
P/FCF Ratio	-	-1.33	-4.40	-	-	-
P/OCF Ratio	-	-1.37	-4.45	-	-	-
EV/Sales Ratio	-	-	236.78	-	-	-
EV/EBITDA Ratio	-	0.03	-0.92	-	-	-
EV/EBIT Ratio	-	0.03	-0.88	-	-	-
EV/FCF Ratio	-	0.03	-1.07	-	-	-
Net Debt / EBITDA Ratio	1.24	1.24	2.86	2.71	1.75	3.04
Net Debt / FCF Ratio	1.36	1.36	3.33	1.52	1.80	9.45
Asset Turnover	-	0	0.00	0.37	0.04	0.02
Return on Assets (ROA)	-61.21%	-61.21%	-51.28%	-34.09%	-45.38%	-57.17%
Return on Capital Employed (ROCE)	-61.21%	-61.21%	-51.28%	-34.17%	-45.42%	-57.17%
Earnings Yield	-30.05%	-79.95%	-57.64%	-	-	-
FCF Yield	-28.43%	-75.19%	-22.74%	-	-	-
Buyback Yield / Dilution	-117.11%	-117.11%	-1302.55%	-4.70%	99.89%	-8.60%
Total Shareholder Return	-117.11%	-117.11%	-1302.55%	-4.70%	99.89%	-8.60%

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q